Steven D. Knight

Steven D. Knight

Auto-generated profile, based on publicly available information

Steven D. Knight

Google, Mountain View, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2023
Verified
Conference Paper
Open access
DWDavid Wetherall
David Wetherall
AKAbdul Kabbani
Abdul Kabbani
VJVan Jacobson
Van Jacobson
JWJim Winget
Jim Winget
YCYuchung Cheng
Yuchung Cheng
AVAmin Vahdat
Amin Vahdat

1 October 2008 in European Journal of Cancer Supplements
Verified
Journal Article
Closed access
KAK.R. Auger
K.R. Auger
LLLiang Luo
Liang Luo
SKS. Knight
S. Knight
GAG. Van Aller
G. Van Aller
PTP.J. Tummino
P.J. Tummino
DDD. Dhanak
D. Dhanak

18 March 2020 in Substance Use & Misuse
Verified
Journal Article
Closed access
PHPatrick Hegde
Patrick Hegde
JSJacob Shreffler
Jacob Shreffler
SKSteven Knight
Steven Knight
RORaymond Orthober
Raymond Orthober
MHMartin Huecker
Martin Huecker
Background: The opioid epidemic continues to challenge the United States, fueled by illicitly manufactured fentanyl. All stakeholders involved in fighting the opioid epidemic, from medical providers to policy makers, will benefit from understanding what contributes to overdoses. Recently incarcerated individuals represent a particularly vulnerable population. Methods: We performed a retrospective review of Jefferson County Coroner data for overdose deaths by postmortem toxicology between January 2017 and December 2018. Patients were cross-referenced with Jefferson County Department of Corrections (DOC) records, with inclusion of individuals with violations after January 2016 to focus on recently incarcerated individuals. We analyzed substances found in toxicology reports and substance risk level assigned based on screening by the DOC. Results: A total of 575 opioid overdose deaths occurred in Jefferson County from 2017-2018, with 55 of these individuals having interaction with the DOC after January 1, 2016. DOC population individuals had statistically significant higher findings of amphetamines/methamphetamines. Individuals from the DOC population had higher frequencies of fentanyl, heroin, cocaine, and cannabinoid/THC; however, these differences were not statistically significant. Prisoners with substance risk assessment scores of high or very high had fewer days from release to overdose death. Conclusion: Fentanyl remains a major contributor to overdose death, including those recently incarcerated. Substance risk assessment tools should drive referral for treatment while in prison and at time of release. These results provide better insight into the opioid epidemic and may help guide medical care, specifically for recently incarcerated individuals.

3 April 2023
Verified
Other
Open access
HOHeidi M. Ott
Heidi M. Ott
AGAlan P. Graves
Alan P. Graves
MPMelissa B. Pappalardi
Melissa B. Pappalardi
MHMichael Huddleston
Michael Huddleston
WHWendy S. Halsey
Wendy S. Halsey
MMMichael T. McCabe
Michael T. McCabe
Supplementary Figure 7: Comparison of the active sites and residue numbering of multiple related lysine methyltransferases

3 April 2023
Verified
Other
Open access
HOHeidi M. Ott
Heidi M. Ott
AGAlan P. Graves
Alan P. Graves
MPMelissa B. Pappalardi
Melissa B. Pappalardi
MHMichael Huddleston
Michael Huddleston
WHWendy S. Halsey
Wendy S. Halsey
MMMichael T. McCabe
Michael T. McCabe
Supplementary Figure 7: Comparison of the active sites and residue numbering of multiple related lysine methyltransferases

3 April 2023
Verified
Other
Open access
HOHeidi M. Ott
Heidi M. Ott
AGAlan P. Graves
Alan P. Graves
MPMelissa B. Pappalardi
Melissa B. Pappalardi
MHMichael Huddleston
Michael Huddleston
WHWendy S. Halsey
Wendy S. Halsey
MMMichael T. McCabe
Michael T. McCabe
Supplementary Figure 6: Gene Set Enrichment Analysis (GSEA) for SUP-B8 cells treated with GSK126